Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
JellyFil Announces Entry into the Men's Wellness Supplement Category with First Product Launch
GlobeNewswire, Inc.
LARGO, FL, June 28, 2026 (GLOBE NEWSWIRE) -- JellyFil, a company established in 2026, today announced its entry into the men's wellness supplement category with the introduction of its first product, JellyFil. The launch marks the company's...
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress
GlobeNewswire, Inc.
New results from HMB-002 first-in-human data validate proof of mechanism in Von Willebrand disease (VWD), elevating Von Willebrand Factor (VWF) and Factor VIII (FVIII) levels with subcutaneous dosing; multiple dose assessment underway New program...
ESO Launches Prehospital Intelligence™ to Reduce Length of Stay and Strengthen EMS-Hospital Collaboration
GlobeNewswire, Inc.
AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- ESO Solutions, Inc. (“ESO”), a leading data services and software provider for EMS, fire departments, hospitals, and government agencies, today announced the launch of ESO Prehospital Intelligence™,...
JellyFil Announces Launch of Men's Vitality Dietary Supplement Across Multiple International Markets
GlobeNewswire, Inc.
LAKELAND, FL, June 23, 2026 (GLOBE NEWSWIRE) -- JellyFil, a newly established company in the men's wellness sector, today announced the launch of JellyFil, a dietary supplement formulated to support men's energy, stamina, libido, and overall...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire, Inc.
Company announcement – No. 27 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 22, 2026 – Zealand Pharma A/S...
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
GlobeNewswire, Inc.
Company announcement No. 26 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 25, 2026) Copenhagen, Denmark, June 22, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Non-Alcoholic Beer Market Anticipated to Grow from USD 21.35Billion in 2025 to USD 43.72B by 2035 due to wellness demand
EIN Presswire
Non-Alcoholic Beer Market is segmented by product type, distribution channel, packaging, flavor profile, and region.
Danish AI scale-up Good Tape and War Correspondent Nagieb Khaja Launch Global 'Names' Campaign to Protect Media Workers
EIN Presswire
Amid Record-Breaking Fatalities of World’s Journalists, Good Tape introduces the “Names” Awareness Campaign and Critical Support for Front-line Media Workers.
New European initiative to accelerate drug discovery for cardiometabolic diseases
GlobeNewswire, Inc.
COPENHAGEN, Denmark, June 19, 2026 (GLOBE NEWSWIRE) -- The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for cardiometabolic diseases (CMDs). The...
HMNC Brain Health appoints Dr. Bjørn Grønning as Chief Medical Officer
GlobeNewswire, Inc.
Pharmaceutical executive and physician with strong experience in global research and development Over 20 years’ experience in all stages of clinical development across multiple indications, including neurology and psychiatry programs Appointment...
SYNAPSE-CMT Phase 2a Clinical Study Data Presented in Late-Breaking Oral Presentation at 2026 PNS Annual Meeting
GlobeNewswire, Inc.
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2a SYNAPSE-CMT...
Univar Solutions Expands Exclusive Beauty, Personal Care, and Pharmaceutical Ingredients Partnership with American Distilling in EMEA
GlobeNewswire, Inc.
ROTTERDAM, The Netherlands, June 17, 2026 (GLOBE NEWSWIRE) -- Univar Solutions B.V., a subsidiary of Univar Solutions LLC (“Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals,...
Medical Simulation Market to reach USD 11.42 Billion by 2035 at 15.12% CAGR
EIN Presswire
Medical Simulation Market to Surge from USD 3.25 Billion in 2026 to USD 11.42 Billion by 2035, Powered by Patient Safety Mandate, AI-Adaptive Learning Platforms NY, CA, UNITED STATES, June 8, 2026 /EINPresswire.com/ -- As per Market Research...
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
GlobeNewswire, Inc.
Company announcement No. 25 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 24, 2026) Copenhagen, Denmark, June 15, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Osteoarthritis Market Expected to Showcase Moderate Growth at a CAGR of 3% During the Forecast Period (2026–2036) Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
GlobeNewswire, Inc.
New York, USA, June 15, 2026 (GLOBE NEWSWIRE) -- Osteoarthritis Market Expected to Showcase Moderate Growth at a CAGR of 3% During the Forecast Period (2026–2036) Driven by Emerging Therapies and Rising Disease Burden | DelveInsight The...
KingsRock Advisors Announces Additional ten Senior Hires, including Wilder Fulford in M&A and Healthcare
GlobeNewswire, Inc.
NEW YORK and LONDON and STOCKHOLM and DUBAI, United Arab Emirates and MUMBAI, India, June 15, 2026 (GLOBE NEWSWIRE) -- KingsRock Advisors, LLC, an independent global advisory firm, announced today the continuation of its growth, with a series of...
Evaxion receives Prix Galien UK Award for Best digital health solution
GlobeNewswire, Inc.
COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien UK Award for Best digital...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire, Inc.
Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 10, 2026 – Zealand Pharma A/S...
Casein and Caseinate Market Expands to US$6.2 Bn Driven by Sports Nutrition
EIN Presswire
The casein and caseinate market is projected to grow steadily from US$ 3.8 Bn in 2026 to US$ 6.2 Bn by 2033, registering a CAGR of 5.6% overall LONDON, LONDON, UNITED KINGDOM, June 11, 2026 /EINPresswire.com/ -- The global casein and caseinate...
Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL
GlobeNewswire, Inc.
PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the treatment of relapsed or refractory...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.